US Patent Issued to Corsair Pharma on June 2 for "Treprostinil derivatives and compositions and uses thereof" (California Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,847, issued on June 2, was assigned to Corsair Pharma Inc. (South San Francisco, Calif.).

"Treprostinil derivatives and compositions and uses thereof" was invented by Xiaoming Zhang (Sunnyvale, Calif.), Meenakshi S. Venkatraman (Fremont, Calif.) and Cyrus K. Becker (Pleasanton, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension."

The patent was filed on Sept. 20, 2023, u...